This week we were pleased to welcome Millie Bone to the Mantell Associates team! She has joined our CDMO team as an Associate, and will be focusing on the Commercial space. Millie brings over three years recruiting experience and we're excited to have her on the MA team! Welcome! #welcome #recruitmentlondon #pharmarecruitment
Mantell Associates
Executive Search Services
City of London, England 118,076 followers
Multidiscipline Global Life Science and Pharmaceutical Headhunting Firm.
About us
Mantell Associates is a multi-discipline headhunting firm focused on providing both permanent and contract recruitment services globally, to the Biotech, Pharmaceutical, CDMO, CRO, Diagnostics, Animal Health, Consulting, Medical Device and MedTech sectors. With success ranging across C-Suite, Commercial, Technical Operations, Scientific, Clinical, Quality and Regulatory, we pride ourselves on our ability to bring the top talent to our clients, and the best opportunities to the top talent. Our services span across our Partnership Service, Contingency, Project Management and Contract models, meaning that we can cater to our client’s every requirement.
- Website
-
www.mantellassociates.com
External link for Mantell Associates
- Industry
- Executive Search Services
- Company size
- 51-200 employees
- Headquarters
- City of London, England
- Type
- Privately Held
- Founded
- 2019
- Specialties
- Contract Development Manufacturing Organisations, Contract Manufacturing Organisations, Preclinical, Active Pharmaceutical Ingredients, Cell & Gene Therapy, Finished Dosage Forms, Biologics, Toxicology, Pharmacology, Oncology, CDMO, CMO, Biomarkers, Vaccines, Contract Research Organisation, Clinical Trial Supplies, Bioanalytics, Bioanalysis, Fine Chemicals, and Highly Potent Active Pharmaceutical Ingredients
Locations
-
Primary
150 Minories
City of London, England EC3N 1LS, GB
-
2 S Biscayne Blvd
Miami, Florida 33131, US
-
Rigistrasse 3
Zug, 6300, CH
Employees at Mantell Associates
Updates
-
Novo Holdings has completed its previously announced acquisition of Catalent Pharma Solutions in an all-cash transaction valued at approximately $16.5 billion. Read more below: https://lnkd.in/eFcCF3m5 #acquisition #pharmanews #pharmaacquisition
-
Don't just listen to us, listen to what our candidates and clients say about us! "I’ve never met a recruitment consultant like Ewan. While it’s all too common for biotech recruiters to burn out, ghost, or even mislead their clients, Ewan’s consistent and human approach transformed what is often a stressful process into an absolute pleasure. Not only did Ewan consistently follow up, but he genuinely listened to my feedback, addressed my concerns thoughtfully, and provided meaningful answers—or connected me with the right individuals who could. Despite a five-hour time zone difference, Ewan always responded promptly and comprehensively, and was only ever a phone call away. Ewan is someone who clearly values quality work. This work ethic, paired with his warm & friendly personality, and passion for connecting Biotechs with talent makes him a standout recruiter. Although Ewan acted as a consultant, I now see him as a trusted advisor and a friend. I look forward to collaborating with Ewan in the future and watching his continued growth in the CDMO recruitment space." Contact Ewan Rennison on +44 (0)20 3854 7700. #testimonialthursday #pharmarecruitment #lifesciencerecruitment
-
Italian VC XGEN Venture has closed a 180 million euro ($190 million) fund for biotech and medtech companies. Read more below: https://lnkd.in/e49q9y9E #medtechnews #biotechfunding #biotechnews
XGEN Venture closes $190M fund with plans to invest in early-stage biotech, medtech firms
fiercebiotech.com
-
In a flurry of decisions Friday, the European Medicines Agency’s human products committee recommended 17 new drugs for approval. Read more below: https://lnkd.in/eayCkSKy #drugdevelopment #drugapproval #newdrugs
EMA backs Merck's Welireg, Bayer's ATTR med and Gilead's liver drug from $4.3B deal
fiercepharma.com
-
AbbVie is paying $200 million to snap up Nimble Therapeutics, a Roche spinout working to develop oral peptide treatments in the autoimmune space. Read more below: https://lnkd.in/eC4BAshM #peptides #autoimmune #acquisition
AbbVie buys Roche spinout Nimble Therapeutics for $200M
fiercebiotech.com
-
New opportunity! Project Change Consultant - Pharma - Denmark. Are you an experienced Project Change and Risk Manager with a strong background in capital construction projects within the pharmaceutical industry? Join our client’s dynamic team in Denmark and play a pivotal role in driving the success of high-profile projects in a rapidly evolving sector. Apply for this role online - https://lnkd.in/eZ4HP8Xx - or contact Rhys Jones on +44 (0)20 3854 7700. #riskjobs #projectmanager #pharmajobs
-
The FDA has opened up the use of Johnson & Johnson’s miniaturized heart pumps to certain pediatric patients, including those suffering from acute heart failure and cardiogenic shock. Read more below: https://lnkd.in/efNBA-YD #fda #pediatric #pharmanews
FDA expands use of J&J's Impella heart pumps to pediatric patients
fiercebiotech.com
-
Amgen is investing $1 billion to establish a second drug substance manufacturing facility in North Carolina. This brings the company's total planned investment in Holly Springs to more than $1.5 billion, building on its previously announced $550 million commitment. Read more below: https://lnkd.in/eQCu3gte #drugsubstance #pharmamanufacturing #pharmanews
Amgen Invests $3B to Expand Mfg. Facility in North Carolina
contractpharma.com
-
Listen to what our clients and candidates have to say... "Fernand was a pleasure to work with during my recent job search. He connected me with a relevant opportunity that was a good match for my skills and experience while providing growth potential and new challenges. He was very communicative throughout the entire process and kept me up to date with the status of my application and next steps. He ensured that I was well prepared for my interviews and was instrumental in helping me to secure a competitive offer that I accepted. I highly recommend Fernand for recruitment within the Life Sciences and CDMO space." Contact Fernand Desjarlais on +44 (0)20 3854 7700. #testimonialtuesday #testimonial #pharmarecruitment